Xiehe Group To Set Up Base In Shenzhen
This article was originally published in PharmAsia News
Executive Summary
China's leading biopharmaceutical company, Shenyang Xiehe Group, has announced it will set up a wholly-owned subsidiary in Shenzhen High-Tech Industrial Park; it will also site its future R&D and international base in the city. Xiehe Group, a multinational conglomerate with 33 subsidiaries worldwide, integrates R&D, production and trading for health care items, biopharmaceuticals and other high-tech products. Its product value is expected to reach RMB 4 billion by 2010. The latest move is an important step in Xiehe Group's rapid growth as it will tap on Shenzhen's advantages in location and manufacturing to reap its R&D translational output as well as expand sales. The company has already established R&D centers in the U.S., Hong Kong and Shenyang. (Click here for more - Chinese Language)